BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32415624)

  • 21. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.
    Zalmaï L; Viailly PJ; Biichle S; Cheok M; Soret L; Angelot-Delettre F; Petrella T; Collonge-Rame MA; Seilles E; Geffroy S; Deconinck E; Daguindau E; Bouyer S; Dindinaud E; Baunin V; Le Garff-Tavernier M; Roos-Weil D; Wagner-Ballon O; Salaun V; Feuillard J; Brun S; Drenou B; Mayeur-Rousse C; Okamba P; Dorvaux V; Tichionni M; Rose J; Rubio MT; Jacob MC; Raggueneau V; Preudhomme C; Saas P; Ferrand C; Adotevi O; Roumier C; Jardin F; Garnache-Ottou F; Renosi F
    Haematologica; 2021 Dec; 106(12):3056-3066. PubMed ID: 33054115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
    Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
    Liao C; Hu NX; Song H; Zhang JY; Shen DY; Xu XJ; Tang YM
    Int J Hematol; 2021 May; 113(5):751-759. PubMed ID: 33392975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A; Sweet K
    J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expansion of dysfunctional CD56-CD16+ NK cells in chronic hepatitis B patients.
    Wijaya RS; Read SA; Schibeci S; Han S; Azardaryany MK; van der Poorten D; Lin R; Yuen L; Lam V; Douglas MW; George J; Ahlenstiel G
    Liver Int; 2021 May; 41(5):969-981. PubMed ID: 33411395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow Cytometric Analysis of Monocytes and Granulocytes May Be Useful in the Distinction of Myeloid Neoplasms from Reactive Conditions: A Single Institution Experience and Literature Review.
    Brown LE; Zhang D; Cui W
    Ann Clin Lab Sci; 2020 May; 50(3):327-332. PubMed ID: 32581021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies.
    Mehra S; Taylor J
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case of Acute Myeloid Leukemia Mimicking Blastic Plasmacytoid Dendritic Cell Neoplasm: Utility of the Proposed Upcoming WHO-5 Diagnostic Criteria.
    Jhajj B; Henrie R; El-Khalidy Y; Moshref Razavi H
    Case Rep Hematol; 2023; 2023():5014728. PubMed ID: 37946878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel.
    Pagano L; Zinzani PL; Pileri S; Quaglino P; Cuglievan B; Berti E; Pemmaraju N; Onida F; Willemze R; Orfao A; Barosi G
    Hemasphere; 2023 Mar; 7(3):e841. PubMed ID: 36844178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey.
    Valentini CG; Piciocchi A; Facchetti F; Guolo F; Pulsoni A; Vignetti M; Pagano L
    Blood Adv; 2021 Dec; 5(24):5608-5611. PubMed ID: 34644376
    [No Abstract]   [Full Text] [Related]  

  • 31. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
    Cheng W; Yu TT; Tang AP; He Young K; Yu L
    Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
    Zhang X; Sun J; Yang M; Wang L; Jin J
    Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic Cell Leukemia: a Review.
    Tsagarakis NJ; Paterakis G
    Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
    Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review.
    Wang Y; Xiao L; Yin L; Zhou L; Deng Y; Deng H
    Medicine (Baltimore); 2023 Feb; 102(7):e32904. PubMed ID: 36800625
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.